Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1854 (LINC01854) is a human long non-coding RNA (lncRNA) transcribed from a genomic region that does not overlap with any protein-coding gene[1]. As a member of the lincRNA family, it belongs to a class of transcripts longer than 200 nucleotides that do not have significant protein-coding potential and often function in the regulation of gene expression at transcriptional or post-transcriptional levels[1][3][5]. The specific biological roles and disease associations of LINC01854 are currently uncharacterized in available public databases, and there is no evidence it is used as a biomarker, therapeutic target, or has safety concerns reported in the literature[1]. Similar lincRNAs have been shown to participate in gene regulation but functional details can be context- and transcript-specific[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1854 (LINC01854).